186 related articles for article (PubMed ID: 36453365)
1. Central retinal vein occlusion as primary ocular manifestation of rhino-orbital-cerebral mucormycosis: A case report.
Sethi NK; Chadha C; Bajaj M; Moond H
Indian J Ophthalmol; 2022 Dec; 70(12):4451-4453. PubMed ID: 36453365
[TBL] [Abstract][Full Text] [Related]
2. Case series of central retinal artery occlusion in COVID-19-associated rhino-orbital-cerebral mucormycosis.
Kamath GM; Jeganathan S; Salim S; Antony RM; Kamath AR; Hiran H
Indian J Ophthalmol; 2023 Jul; 71(7):2904-2906. PubMed ID: 37417144
[TBL] [Abstract][Full Text] [Related]
3. Central retinal artery occlusion as the presenting manifestation of invasive rhino-orbital-cerebral mucormycosis.
Bawankar P; Lahane S; Pathak P; Gonde P; Singh A
Taiwan J Ophthalmol; 2020; 10(1):62-65. PubMed ID: 32309127
[TBL] [Abstract][Full Text] [Related]
4. Bilateral blindness in a young male of rhino-orbital-cerebral mucormycosis: A case report.
Kaur R; Sehgal A; Khan B; Budhiraja G; Roychoudhury AK; Kaur M
Indian J Ophthalmol; 2022 May; 70(5):1822-1824. PubMed ID: 35502084
[TBL] [Abstract][Full Text] [Related]
5. Rhino-orbital mucormycosis in a patient with no susceptibility following P.vivax malaria infection-a case report.
Prasad S; Gaur A; Mehta A; Kaushal N
BMC Ophthalmol; 2022 Oct; 22(1):389. PubMed ID: 36183076
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study.
Boyer D; Heier J; Brown DM; Clark WL; Vitti R; Berliner AJ; Groetzbach G; Zeitz O; Sandbrink R; Zhu X; Beckmann K; Haller JA
Ophthalmology; 2012 May; 119(5):1024-32. PubMed ID: 22440275
[TBL] [Abstract][Full Text] [Related]
7. Exudative retinal detachment in COVID-19 - associated rhino-orbital mucormycosis - A rare clinical finding.
Sarkar S; Gokhale T; Kaliaperumal S; Singh R; Begam RB; Deb AK
Indian J Ophthalmol; 2021 Sep; 69(9):2535-2537. PubMed ID: 34427262
[TBL] [Abstract][Full Text] [Related]
8. Unilateral rhino-orbital-cerebral mucormycosis with contralateral endogenous fungal endophthalmitis.
Ho HC; Liew OH; Teh SS; Hanizasurana H; Ibrahim M; Shatriah I
Clin Ophthalmol; 2015; 9():553-6. PubMed ID: 25848206
[TBL] [Abstract][Full Text] [Related]
9. A Case of Bilateral Central Retinal Artery Occlusion in a Post-COVID Rhino-Orbital-Cerebral Mucormycosis Patient.
Patnaik A; Sharma B; Ahmad R; Kumar A; Chitrotpala R; Gupta M
Cureus; 2021 Nov; 13(11):e20062. PubMed ID: 35003938
[TBL] [Abstract][Full Text] [Related]
10. Clinico-Radiological-Pathological Correlation of Visual Loss in COVID-Associated Rhino-Orbito-Cerebral Mucormycosis.
Goel R; Arora R; Shah S; Chhabra M; Kumar J; Khurana N; Gupta S; Khanam S; Kumar S; Singh S; Meher R; Thakar M; Garg A
Ophthalmic Plast Reconstr Surg; 2022 May-Jun 01; 38(3):242-249. PubMed ID: 34919070
[TBL] [Abstract][Full Text] [Related]
11. SCORE2 Report 2: Study Design and Baseline Characteristics.
Scott IU; VanVeldhuisen PC; Ip MS; Blodi BA; Oden NL; Figueroa M; Dugel PU;
Ophthalmology; 2017 Feb; 124(2):245-256. PubMed ID: 27863843
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.
Cekiç O; Chang S; Tseng JJ; Barile GR; Weissman H; Del Priore LV; Schiff WM; Weiss M; Klancnik JM
Retina; 2005; 25(7):846-50. PubMed ID: 16205562
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
[TBL] [Abstract][Full Text] [Related]
14. Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.
Blanc J; Deschasse C; Kodjikian L; Dot C; Bron AM; Creuzot-Garcher C
Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1441-1448. PubMed ID: 29855706
[TBL] [Abstract][Full Text] [Related]
15. Photocoagulation for retinal vein occlusion.
Hayreh SS
Prog Retin Eye Res; 2021 Nov; 85():100964. PubMed ID: 33713810
[TBL] [Abstract][Full Text] [Related]
16. Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.
Aref AA; Scott IU; VanVeldhuisen PC; King J; Ip MS; Blodi BA; Oden NL;
JAMA Ophthalmol; 2021 Dec; 139(12):1285-1291. PubMed ID: 34709363
[TBL] [Abstract][Full Text] [Related]
17. SCORE2 Report 5: Vision-Related Function in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion.
Scott IU; Figueroa MJ; Oden NL; Ip MS; Blodi BA; VanVeldhuisen PC;
Am J Ophthalmol; 2017 Dec; 184():147-156. PubMed ID: 29074161
[TBL] [Abstract][Full Text] [Related]
18. Longer-Term Anti-VEGF Therapy Outcomes in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Vein Occlusion-Related Macular Edema: Clinical Outcomes in 130 247 Eyes.
Ciulla TA; Hussain RM; Taraborelli D; Pollack JS; Williams DF
Ophthalmol Retina; 2022 Sep; 6(9):796-806. PubMed ID: 35381391
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Follow-Up Changes of Central Choroidal Thickness Thinning after Repeated Anti-VEGF Therapy Injections in Patients with Central Retinal Vein Occlusion-Related Macular Edema with Systemic Hypertension.
Kida T; Osuka S; Fukumoto M; Sato T; Harino S; Oku H; Ikeda T
Ophthalmologica; 2020; 243(2):102-109. PubMed ID: 31851998
[TBL] [Abstract][Full Text] [Related]
20. Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion.
de Salles MC; Epstein D
Graefes Arch Clin Exp Ophthalmol; 2021 Sep; 259(9):2653-2660. PubMed ID: 33738625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
